1. Home
  2. WRAP vs MRNS Comparison

WRAP vs MRNS Comparison

Compare WRAP & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRAP
  • MRNS
  • Stock Information
  • Founded
  • WRAP 2016
  • MRNS 2003
  • Country
  • WRAP United States
  • MRNS United States
  • Employees
  • WRAP N/A
  • MRNS N/A
  • Industry
  • WRAP Ordnance And Accessories
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WRAP Industrials
  • MRNS Health Care
  • Exchange
  • WRAP Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • WRAP 68.8M
  • MRNS 104.7M
  • IPO Year
  • WRAP N/A
  • MRNS 2014
  • Fundamental
  • Price
  • WRAP $1.70
  • MRNS $0.31
  • Analyst Decision
  • WRAP
  • MRNS Buy
  • Analyst Count
  • WRAP 0
  • MRNS 12
  • Target Price
  • WRAP N/A
  • MRNS $4.56
  • AVG Volume (30 Days)
  • WRAP 191.1K
  • MRNS 5.7M
  • Earning Date
  • WRAP 10-15-2024
  • MRNS 11-05-2024
  • Dividend Yield
  • WRAP N/A
  • MRNS N/A
  • EPS Growth
  • WRAP N/A
  • MRNS N/A
  • EPS
  • WRAP N/A
  • MRNS N/A
  • Revenue
  • WRAP $7,269,000.00
  • MRNS $30,263,000.00
  • Revenue This Year
  • WRAP N/A
  • MRNS $21.18
  • Revenue Next Year
  • WRAP N/A
  • MRNS $56.42
  • P/E Ratio
  • WRAP N/A
  • MRNS N/A
  • Revenue Growth
  • WRAP 0.99
  • MRNS 16.56
  • 52 Week Low
  • WRAP $1.21
  • MRNS $0.26
  • 52 Week High
  • WRAP $7.01
  • MRNS $11.26
  • Technical
  • Relative Strength Index (RSI)
  • WRAP 56.79
  • MRNS 21.75
  • Support Level
  • WRAP $1.71
  • MRNS $0.29
  • Resistance Level
  • WRAP $1.93
  • MRNS $1.96
  • Average True Range (ATR)
  • WRAP 0.16
  • MRNS 0.12
  • MACD
  • WRAP 0.01
  • MRNS -0.18
  • Stochastic Oscillator
  • WRAP 61.70
  • MRNS 2.41

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: